Breast HER2 Insitu Hybridization (HER2 ISH): Acceptable and unacceptable staining criteria impacting on interpretation

被引：0
|
作者：
Parry, S. [1 ]
Miller, K. [1 ]
Ibrahim, M. [1 ]
机构：
[1] UK NEQAS ICC & ISH, London, England
来源：
VIRCHOWS ARCHIV | 2012年 / 461卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [21] The INFORM HER2 Dual ISH assay compared with FISH to determine HER2 gene status in invasive breast carcinoma
    Loftin, I. R.
    McElhinny, A.
    Miller, R.
    Garcia, C.
    Bai, I.
    Ranger-Moore, J.
    Ostrem, J.
    Padilla, M.
    Grogan, T. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [22] The role of serum HER2 as an alternative to fluorescence in situ hybridization for HER2 in metastatic breast cancer.
    Kong, SY
    Kwon, Y
    Lee, DH
    Lee, JS
    Lee, ES
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 48S - 48S
  • [23] ISH-based HER2 diagnostics; [ISH-basierte HER2-Diagnostik]
    Rüschoff J.
    Nagelmeier I.
    Jasani B.
    Stoss O.
    Der Pathologe, 2021, 42 (Suppl 1): : 62 - 68
  • [24] Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
    Lauterlein, Jens-Jacob L.
    Petersen, Eva R. B.
    Olsen, Dorte Aa
    Ostergaard, Birthe
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 877 - 883
  • [25] Enhancing HER2 evaluation: Correlation of APIS Breast Cancer Subtyping Kit and IHC/ISH with accurate HER2 quantification.
    Gasior, Anna
    Wegscheider, Anne-Sophie
    Paveley, Jack
    Howard, Kimberly Jane
    Harrison, Mathew
    Gough, Leanne
    Gorniak, Joanna
    Rollinson, Sara
    Pounce, Zoe
    Niendorf, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Enhancing HER2 Evaluation: Correlation between APIS Breast Cancer Subtyping Kit and IHC/ISH for Accurate HER2 Quantification
    Gasior, Anna
    Gorniak, Joanna
    Rollinson, Sara
    Gough, Leanne
    Wegscheider, Anne-Sophie
    Niendorf, Axel
    CANCER RESEARCH, 2024, 84 (09)
  • [27] Advancing HER2 Stratification: Evaluating the APIS Breast Cancer Subtyping Kit against IHC/ISH for Precise HER2 Quantification
    Gasior, A.
    Wegscheider, A.
    Gorniak, J.
    Rollinson, S.
    Gough, L.
    Howard, K.
    Pounce, Z.
    Niendorf, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S93 - S93
  • [28] Correlation of In Situ HER2 RNA Expression With HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Categories in Breast Cancer
    Tseng, Yu-Fen
    Li, Yu-Chia
    Lee, Yi-Hsuan
    Hu, Hsiang-We
    Zhang, Man-San
    Hung, Tze-Chun
    Lien, Huang-Chun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (03) : e48 - e56
  • [29] Enhancing HER2 Evaluation: Correlation between APIS Breast Cancer Subtyping Kit and IHC/ISH for Accurate HER2 Quantification
    Gasior, A.
    Gorniak, J.
    Rollinson, S.
    Gough, L.
    Wegscheider, A.
    Niendorf, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S105 - S105
  • [30] Enhancing HER2 Evaluation: Correlation between APIS Breast Cancer Subtyping Kit and IHC/ISH for Accurate HER2 Quantification
    Gasior, Anna
    Gorniak, Joanna
    Howard, Kimberly
    Harrison, Mathew
    Gough, Leanne
    Rollinson, Sara
    Pounce, Zoe
    Wegscheider, Anne-Sophie
    Niendorf, Med. Axel
    JOURNAL OF PATHOLOGY, 2024, 264 : S24 - S24
12345